Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company's investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. Wyeth is ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that voclosporin is positioned to enter a Phase 1 clinical trial as the drug utilized in the CINATRA(TM) Drug Coated Coronary Stent system developed by the Company's partner, Atrium Medical Corporation. Atrium has received approval from the ...
London (ots/PRNewswire) - - Year-Long Campaign Titled 'Optimum Health and Nutrition' to Focus on the Link Between Nutrition and Digestive Health - Poor Digestive Health Affects Millions Worldwide and Seriously Impacts Quality of Life, yet few Seek Medical Advice - WGO and Danone Committed to Working ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) today announced positive results from the Phase 2b PROMISE trial which evaluated the Company's lead drug, voclosporin , in de novo kidney transplant patients. This trial was designed to determine the most appropriate dosing strategy for the Phase 3 program in kidney transplantation. "PROMISE has shown that the efficacy of voclosporin is statistically ...
Vancouver, British Columbia (ots/PRNewswire) - Mawson Resources Limited ("Mawson") TSX - MAW; Frankfurt - MRY. Michael Hudson, President & CEO, announces the first results from the Company's 40 hole, 1,724 metre winter diamond drill program at the Tasjo uranium - rare earth element (REE) - phosphate project in Sweden. Results are available for the first 8 holes (BODDD08001 to BODDD08004, BODDD08007, BODDD08013 and ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) reports that it has arranged a private placement of 2,750,000 units at a price of CAD$0.40 per Unit for gross proceeds of CAD$1,100,000. Each Unit will consist of one common share and one full warrant entitling the holder to purchase a common share at a price of CAD$0.50 for a period of 24 months after closing. Completion of the ...
Amsterdam Molecular Therapeutics B.V
Amsterdam, The Netherlands (ots/PRNewswire) - - Production Increase Brings Large Disease Areas Within Reach Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a Cooperative Research and Development Agreement from the National Heart, Lung, and Blood Institute (NHLBI) of the National ...
University of Massachusetts Medical School
Barcelona, Spain (ots/PRNewswire) - - In Europe, Less Screening and Treatment, and an Apparent Higher Prevalence of Hip Fracture Than in North America and Australia In a first-of-its-kind study in osteoporosis, one in four women surveyed from Europe, North America, and Australia reported having one or more bone fractures since the age of 45 years. Among ...
Istanbul, Turkey (ots/PRNewswire) - - New Studies Provide Clinical Support for More Flexible and Convenient Dosing Options for Patients New data from key clinical trials presented today at the 5th European Academy of Dermatology and Venereology (EADV) Spring Symposium in Istanbul, demonstrate that ...
Quebec City, Canada (ots/PRNewswire) - - UNIPEX Group Finalizes Acquisition of Atrium Innovations' Active Ingredients & Specialty Chemicals Division UNIPEX Group is pleased to announce the successful completion of its acquisition of the Active Ingredients & Specialty Chemicals Division of Atrium ...
Amsterdam Molecular Therapeutics B.V
Amsterdam, The Netherlands (ots/PRNewswire) - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from La Sapienza University in Rome, Italy, to their advanced small nuclear RNA (snRNA)-based exon-skipping technology for the treatment of Duchenne muscular dystrophy (DMD). The ...
San Diego (ots/PRNewswire) - - Three Presentations and Four Additional Posters Reinforce Efficacy and Safety Profile of RESOLOR Movetis NV, a European-based GI specialist pharmaceutical company, today announces that it has presented substantial new data from different studies this week at the prestigious Digestive Disease Week (DDW) 2008 Congress. The data, that are part of a comprehensive development program ...
San Jose, California (ots/PRNewswire) - - Industrial Software Technology to Provide Java Solutions to Increase Development Productivity for AVR32 AP7 Series Atmel(R) Corporation (Nasdaq: ATML) and Industrial Software Technology(TM) S.A. announced today the industry's most integrated solutions to design ...
Buenos Aires, Argentina (ots/PRNewswire) - Today at the World Congress of Cardiology (WCC), the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology, St George's University of London, highlighted the importance of the newly announced ...
Toronto (ots/PRNewswire) - - Data Presented at the 2008 International Conference of the American Thoracic Society Laboratorios Almirall, S.A. and Forest Laboratories, Inc. today presented results from four clinical trials assessing the efficacy and safety of aclidinium bromide, an investigational ...
Shanghai, China (ots/PRNewswire) - China International Automotive Electronics Show -- Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the new fully integrated fractional-N PLL RF transmitter IC ATA5749 for car access and TPMS applications. The new device is one of the very few ...
London (ots/PRNewswire) - - First EMEA Licensed Treatment Specifically for LGS Offers New Hope for Patients With Epilepsy Eisai Europe Limited, (Headquarters: London, Chairman and CEO Yutaka Tsuchiya) today announced publication of the results of a major study of its new anti-epileptic agent Inovelon (rufinamide) indicated for adjunctive therapy in ...
Shanghai, China (ots/PRNewswire) - China International Automotive Electronics Show, Shanghai -- Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the new high-temperature hex half-bridge driver ICs ATA6837 and ATA6839. The ATA6837 and ATA6839 are manufactured using Atmel's high-voltage ...
Montreal, Canada (ots/PRNewswire) - - All Dollar Amounts are Expressed in Canadian Dollars Petrolympic Ltd. ("Petrolympic" or the "Company") (TSX VENTURE: PCQ.V) is pleased to announce that it has entered into a binding letter of agreement (the "Agreement") with Ressource & Energie Squatex inc. ("Squatex") pursuant to which Petrolympic will acquire a 30% legal and beneficial interest in 36 exploration ...
London and Paris (ots/PRNewswire) - - Latest Orange Travel Solutions Deliver Significant Savings - Favourite Countries Offers Between 18-60 % Savings on Voice Roaming - Travel Data Daily Offers up to 90 % Savings on Data Roaming Orange, one of the world's leading telecommunications operators, today announced the launch of two new innovative voice and ...
Basel, Switzerland (ots/PRNewswire) - - Roche Supports Patient Groups and International Health Bodies to Call for Increased Resources to Fight Viral Hepatitis - a Major Global Killer A staggering one in 12 people globally are estimated to be infected with chronic hepatitis B or C - this equates to around 500 million people worldwide.(1,2) What is even more alarming is that in some European countries up to 98% of people infected with viral hepatitis and have not ...
Hoofddorp, Netherlands (ots/PRNewswire) - CEVA Group Plc will publish its Quarter 1 2008 results on Friday, May 23, 2008. The Interim Financial Statement will be made available on CEVA's website http://www.cevalogistics.com at 09:00 GMT. A press release with the highlights of the Report will be issued the same date. CEVA. Making Business Flow CEVA Logistics ...
Paris (ots/PRNewswire) - Orange today announced a new agreement with Apple to bring the iPhone to Orange customers in Austria, Belgium, the Dominican Republic, Egypt, Jordan, Poland, Portugal, Romania, Slovakia, Switzerland and Orange's African markets later this year. About Orange Orange is the key brand of France Telecom, one of the world's leading ...
London (ots/PRNewswire) - Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology ...
London (ots/PRNewswire) - - Phase II Data Presented at ASCO Showed Acceptable Tolerability Profile, with Low Incidence of Grade 3 and 4 Neuropathy Eisai Europe Ltd. The investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with ...
Abbott Park, Illinois (ots/PRNewswire) - - New Device Designed to Provide Fast, Safe and Secure Vessel Closure Following Catheterization Procedures Abbott today announced the launch of the StarClose(R) SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast, safe and secure closure of the femoral artery access site ...
Basel, Switzerland (ots/PRNewswire) - Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R) (trastuzumab) following new data that is being presented at the 44th American Society of Clinical Oncology (ASCO) annual meeting in Chicago at the end of May. ...
Winnipeg, Canada (ots/PRNewswire) - Frontiers North Adventures, the premiere provider of Authentic Arctic Experiences in Canada's north, is on record pace for another successful year in the tourism industry. Owners and operators of the Tundra Buggy(R) Adventure, Frontiers North currently offers wildlife viewing programs in Manitoba, Nunavut, and British ...
Paris (ots/PRNewswire) - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that findings from the landmark ATHENA study showed that Multaq(R) (dronedarone), a potential therapy for the treatment of patients with atrial fibrillation or atrial flutter, decreased the risk of cardiovascular ...
St. Peter Port, Guernsey (ots/PRNewswire) - European Capital Limited (LSE: ECAS) ("European Capital"), announced today that it has invested US$57 million in the Qioptiq Group, a leading designer, developer and manufacturer of high-precision optical solutions for the defence, medical and industrial markets. The investment was led by the Paris office of European ...